Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
1187.7000 -13.50 (-1.12%)
NSE Apr 22, 2025 15:54 PM
Volume: 494.9K
 

logo
Aurobindo Pharma Ltd.
12 Nov 2024
1187.70
-1.12%
buy
by Axis Direct
Target: 1460 | Upside : 22.9%
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a target price of Rs 1,460/share.
 
Aurobindo Pharma Ltd. has an average target of 1501.00 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Market closes higher, Pitti Engineering's revenue surges 43% YoY to Rs 468.8 crore in Q4
Trendlyne Marketwatch | 22 Apr 2025, 03:54PM
IPOs This Week: Tankup Engineers' Issue Opens
| 21 Apr 2025, 04:01PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020